邮购药房市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00008558
  • Category : Pharmaceuticals
  • No. of Pages : 150
Buy Now

Mail Order Pharmacy Market Trends and Size (2021-2031)

Buy Now

2023 年邮购药房市场规模估计为 899 亿美元,预计到 2031 年将达到 3165.7 亿美元;预计 到 2031 年的复合年增长率为 17.0%。采用软件技术进行数据集成可能仍是邮购药房市场的关键趋势。

邮购药品市场分析

以患者为中心的护理日益受到重视、医疗技术的进步、具有成本效益的解决方案以及对便捷医疗服务的需求是邮购药房市场增长的主要推动力。此外,老年人口的增加、家庭医疗保健意识的增强、慢性病和传染病的患病率的增加以及对发展中国家邮购药房好处的认识也在推动市场的增长。

邮购药品市场概况

邮购药房通过互联网运营,通过邮件、运输公司或在线药房门户网站发送订单,然后将所需药物送到家门口。邮购药房比当地药房更便宜、更方便。由于医疗保健行业越来越多地采用在线服务,邮购药房服务的采用在过去几年中以前所未有的速度增长。此外,人口老龄化、慢性病患病率上升以及不遵守处方药规定进一步强调了全球邮购药房的采用。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

邮购药品市场:

Mail Order Pharmacy Market: Strategic Insights

Mail Order Pharmacy Market
  • CAGR
    CAGR (2023 - 2031)
    17.0%
  • Market Size 2023
    US$ 89.90 Billion
  • Market Size 2031
    US$ 316.57 Billion

Key Players

  • Canada Drugs Online
  • WellDyne
  • Walgreens co
  • eDrugstore com
  • Zur Rose Group AG
  • CHI Health
  • Optumrx Inc
  • Express Scripts Holding Company
  • CVS Health
  • PillPack

Regional Overview

Regional And Country Scope
  • 北美(美国、加拿大、墨西哥)
  • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
  • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
  • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
  • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)

Market Segmentation

Segment 1药品类型(处方药、非处方药)
    Segment2产品(糖尿病药物、哮喘药物、降压药物、心血管药物、感冒流感药物、抗酸药、止痛药、皮肤护理药物、其他)
      Segment3订购方式(网上商店、药房应用程序)

        邮购药品市场
        • Mail Order Pharmacy Market
          复合年增长率(2023 - 2031)
          17.0%
        • 2023 年市场规模
          899 亿美元
        • 市场规模 2031年
          3165.7亿美元

        市场动态

        增长动力
        • 疾病患病率不断上升
        • 邮购药店的普及率不断提高
        未来的趋势
        • 財政部
        • 財政部
        • 財政部
        机会
        • 增加对邮购药店初创企业的投资

        关键人物;主力;重要一员

        • 加拿大网上药品
        • 威尔达因
        • 沃尔格林公司
        • eDrugstore.com
        • Zur Rose 集团股份公司。
        • CHI 健康
        • Optumrx 公司
        • 快捷药方控股公司
        • CVS 健康
        • PillPack

        区域概况

        Mail Order Pharmacy Market
        • 北美
        • 欧洲
        • 亚太
        • 南美洲和中美洲
        • 中东和非洲

        市场细分

        Mail Order Pharmacy Market药物类型
        • 处方药
        • 非处方药
        Mail Order Pharmacy Market产品
        • 糖尿病药物
        • 哮喘药物
        • 降压药
        • 心血管药物
        • 感冒和流感药物
        • 抗酸药
        • 止痛药
        • 皮肤护理药品
        • 其他的
        Mail Order Pharmacy Market订购方式
        • 网上商城
        • 药店应用程序
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        邮购药房市场驱动因素和机遇

        医疗保健领域越来越多地采用邮购药房

        邮购药房服务在过去几年中呈现出显著的增长模式,目前每年涉及全球数十亿张处方的邮寄。许多雇主提供邮购药房选项作为其综合处方福利的一部分。此外,由于邮购药房业务在全球范围内越来越受欢迎且越来越被采用,许多零售巨头也纷纷涉足该业务。为了避免在药店排队,消费者已经转向数字药房服务。随着邮购药房服务提供商的订单量增加,各公司都扩大了服务范围以满足不断增长的需求。此外,对邮购药房的需求不断增长为许多新公司在这个领域提供广泛的服务铺平了道路。因此,消费者越来越多地采用邮购药房正在推动邮购药房市场的增长。

        加大对邮购药店初创企业的投资——邮购药店市场的机遇

        邮购药房服务初创企业的数量正在增加,对邮购药房的投资正在成为投资者有利可图的商业模式。专业药房的这一细分市场正在快速增长,提供丰厚的机会,并吸引了大量投资者的资金。随着投资的不断流入,对互联网的依赖以及对无忧送货的需求导致独立邮购药房的数量增加,从而为参与者在全球范围内扩展业务提供了大量机会。例如,2024 年 4 月,在线药房初创公司 PlatinumRx 从 India Quotient 和一群杰出的天使投资者那里获得了 80 万美元的种子资金。这笔投资凸显了人们越来越认识到在线药房在确保负担得起且可获得的医疗保健解决方案方面发挥的关键作用,尤其是在慢性病增加和医疗费用不断上涨的背景下。

        邮购药店市场报告细分分析

        有助于得出邮购药品市场分析的关键部分是药品类型、产品和订购方式。

        • 根据药品类型,邮购药房市场分为处方药和非处方药。非处方药部分在 2023 年占据了最大的市场份额。
        • 根据产品,市场细分为糖尿病药物、哮喘药物、降压药物、心血管药物、感冒和流感药物、抗酸药、止痛药、皮肤护理药物等。2023 年,皮肤护理药物占据了最大的市场份额。
        • 就订购方式而言,市场分为在线商店和药店应用程序。2023 年,在线商店占据了最大的市场份额。

        邮购药店市场份额按地区分析

        邮购药房市场报告的地理范围主要分为五个地区:北美洲、亚太地区、欧洲、中东和非洲、南美洲和中美洲。

        北美在邮购药房市场占据主导地位。在北美,美国占据了邮购药房市场的很大份额。北美的增长特点是慢性病和传染病患病率高、医疗支出不断增长、医疗保健领域互联网服务的采用率上升、在线服务的采用率提高、服务提供商数量增加以及医疗机构不断发展。

        邮购药房市场报告范围

        报告属性细节
        2023 年的市场规模899亿美元
        2031 年市场规模3165.7亿美元
        全球复合年增长率(2023 - 2031)17.0%
        历史数据2021-2022
        预测期2024-2031
        涵盖的领域按药物类型
        • 处方药
        • 非处方药
        按产品
        • 糖尿病药物
        • 哮喘药物
        • 降压药
        • 心血管药物
        • 感冒和流感药物
        • 抗酸药
        • 止痛药
        • 皮肤护理药品
        • 其他的
        按订购方式
        • 网上商城
        • 药店应用程序
        覆盖地区和国家北美
        • 我们
        • 加拿大
        • 墨西哥
        欧洲
        • 英国
        • 德国
        • 法国
        • 俄罗斯
        • 意大利
        • 欧洲其他地区
        亚太
        • 中国
        • 印度
        • 日本
        • 澳大利亚
        • 亚太其他地区
        南美洲和中美洲
        • 巴西
        • 阿根廷
        • 南美洲和中美洲其他地区
        中东和非洲
        • 南非
        • 沙特阿拉伯
        • 阿联酋
        • 中东和非洲其他地区
        市场领导者和主要公司简介
        • 加拿大网上药品
        • 威尔达因
        • 沃尔格林公司
        • eDrugstore.com
        • Zur Rose 集团股份公司。
        • CHI 健康
        • Optumrx 公司
        • 快捷药方控股公司
        • CVS 健康
        • PillPack
        • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

        邮购药品市场新闻和最新发展

        邮购药房市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是病毒抗原和策略市场发展的列表:

        • 礼来公司通过其网站推出了肥胖症药物、糖尿病药物和偏头痛药物的在线送货上门服务。该公司的新服务名为 LillyDirect,依靠 Eversana 和 Truepill 等在线药店提供商来配送礼来处方药。(来源:Industry Dive,新闻稿,2024 年)
        • 在线超级专科药店 MrMed 已筹集 50 万美元,由泰米尔纳德邦新兴行业种子基金 (TNESSF) 领投,该基金由泰米尔纳德邦基础设施基金管理有限公司管理。此轮融资还吸引了 BEEJ Network 和 Vish Entrepreneurs LLP 的参与。所得款项将用于营销计划、扩大团队以及探索制药供应链和医疗保健服务提供商领域的新业务(来源:Bareback Media Pvt. Ltd,新闻稿,2023 年)

        邮购药房市场报告覆盖范围和交付成果

        “邮购药房市场规模和预测(2021-2031 年)”报告对市场进行了详细分析,涵盖以下领域:

        • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
        • 市场动态,如驱动因素、限制因素和关键机遇
        • 未来主要趋势
        • 详细的 PEST/波特五力分析和 SWOT 分析
        • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
        • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
        • 详细的公司简介

        Mail Order Pharmacy Market Report Scope

        Report Attribute Details
        Market size in US$ 89.90 Billion
        Market Size by US$ 316.57 Billion
        Global CAGR 17.0%
        Historical Data 2021-2022
        Forecast period 2024-2031
        Segments Covered By 药品类型(处方药、非处方药)
        By 产品(糖尿病药物、哮喘药物、降压药物、心血管药物、感冒流感药物、抗酸药、止痛药、皮肤护理药物、其他)
        By 订购方式(网上商店、药房应用程序)
        Regions and Countries Covered 北美(美国、加拿大、墨西哥)
        • 北美(美国、加拿大、墨西哥)
        欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        • 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
        亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        • 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
        南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        • 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
        中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        • 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
        Market leaders and key company profiles
      • Canada Drugs Online
      • WellDyne
      • Walgreens co
      • eDrugstore com
      • Zur Rose Group AG
      • CHI Health
      • Optumrx Inc
      • Express Scripts Holding Company
      • CVS Health
      • PillPack
      • Report Coverage
        Report Coverage

        Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

        Segment Covered
        Segment Covered

        This text is related
        to segments covered.

        Regional Scope
        Regional Scope

        North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

        Country Scope
        Country Scope

        This text is related
        to country scope.

        The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

        1. Data Collection and Secondary Research:

        As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

        Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

        1. Primary Research:

        The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

        For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

        A typical research interview fulfils the following functions:

        • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
        • Validates and strengthens in-house secondary research findings
        • Develops the analysis team’s expertise and market understanding

        Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

        • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
        • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

        Below is the breakup of our primary respondents by company, designation, and region:

        Research Methodology

        Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

        1. Data Analysis:

        Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

        • Macro-Economic Factor Analysis:

        We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

        • Country Level Data:

        Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

        • Company Profile:

        The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

        • Developing Base Number:

        Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

        1. Data Triangulation and Final Review:

        The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

        We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

        We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

        Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

        Trends and growth analysis reports related to Pharmaceuticals : READ MORE..